title: Emerging therapeutic targets in osteoncology.
authors: Daniele
authors: D
authors: Santini
authors: Francesco
authors: F
authors: Pantano
authors: Bruno
authors: B
authors: Vincenzi
authors: Giuseppe
authors: G
authors: Tonini
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D001859:Bone Neoplasms / Q000188:drug therapy* / Q000556:secondary*; D054377:Chemokine CXCL12; D000069448:Denosumab; D006801:Humans; D058990:Molecular Targeted Therapy; D010455:Peptides / Q000627:therapeutic use; D053245:RANK Ligand / Q000627:therapeutic use; D019718:Receptors, CXCR4; D015398:Signal Transduction / Q000187:drug effects
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C540323:CTCE-9908; D054377:Chemokine CXCL12; D010455:Peptides; D053245:RANK Ligand; D019718:Receptors, CXCR4; C505688:TNFSF11 protein, human; D000069448:Denosumab